The company said it is evaluating its strategic options regarding ADX-097 as it shifts efforts over to pushing bempikibart.

In a new JAMA Dermatology study, scientists at King's College London found that changes in two parts of the genome work ...

In a new study, researchers have found that changes in two parts of the genome work together to influence alopecia risk.

If you struggle with hair loss, you probably have come up with a hundred possible reasons that could be causing it: from ...

Alopecia refers to hair loss and can affect the scalp, eyebrows, eyelashes, and other areas of the body. There are different types of alopecia including an | Immunology ...

The European Medicines Agency has started a review of medicines containing finasteride and dutasteride following concerns ...

Atopy from food allergies to environmental factors can increase hair loss prevalence among children and adults, according to ...

Q32 Bio (Nasdaq: QTTB) has announced a corporate restructuring, shifting its focus entirely to the development of its lead ...

The owner of a longstanding Shropshire salon supplying wigs for NHS patients with hair loss has just opened a second site in ...

Q32 Bio Inc. (Nasdaq: QTTB) ("Q32 Bio"), a clinical stage biotechnology company focused on developing biologic therapeutics to restore immune homeostasis, today announced a corporate restructuring to ...

First-line treatment with enfortumab vedotin and pembrolizumab provides durable benefits over chemotherapy in advanced urothelial carcinoma.